Alisha Tuck: Navigating the First Trimester with Ultrasound and Anticoagulation Management
Alisha Tuck, Obstetrics and Gynecology Sonographer at Sonopartners, LLC, shared a post on LinkedIn:
“Navigating the First Trimester: Ultrasound and Anticoagulation Management
The first trimester is a critical window for patients with known thrombophilias or clotting disorders.
For these individuals, the physiological changes of pregnancy – which naturally induce a hypercoagulable state – intersect with preexisting risks, necessitating a high-stakes balance of anticoagulation therapy.
As Sonographers, we are the ‘eyes’ of the clinical team, providing the diagnostic data that guides these delicate management decisions.
Scanning Considerations and Patient Care
- Gentle Technique: If a subchorionic hemorrhage is present, use a gentle touch with the endovaginal transducer to minimize patient discomfort and avoid aggravating any active bleeding.
- The ‘Double Check’ for Ectopic: Patients with clotting disorders may have undergone fertility treatments (IVF), increasing the risk of heterotopic or ectopic pregnancies. Always sweep the adnexa thoroughly, even if an intrauterine pregnancy (IUP) is confirmed.
- Patient Communication: These patients are often highly anxious. While we cannot provide a diagnosis, maintaining a calm, professional demeanor and confirming that we are ‘taking all necessary measurements for the doctor to review’ can be incredibly grounding.
Summary Checklist for the Sonographer
- Gestational Sac-Location, Shape, Mean Sac Diameter. Rule out ectopic; assess for ‘low implantation’
- Yolk Sac- Presence and Diameter. Early indicator of pregnancy health
- CRL -Best measurement of 3 Critical for future growth monitoring
- Hematoma-Size (cm), Location, % of sac perimeter. Guides anticoagulant dosing adjustments
- Adnexa- Ovaries, free fluid, or masses. Rule out hemorrhage or secondary complications
Conclusion
Sonographers play a pivotal role in the multidisciplinary care of the high-risk obstetric patient.
By providing meticulous documentation of the early pregnancy and any associated perigestational bleeding, we allow the clinical team to tailor anticoagulation therapy – optimizing the safety of both the mother and the developing embryo.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session
-
Jul 13, 2026, 05:57Alberto Maino: ISTH 2026 Has Just Begun
-
Jul 13, 2026, 05:56Karin Knobe: Fresh Insights and Familiar Faces from ISTH 2026